Progressive behavioural changes in the spatial open-field in the quinolinic acid rat model of Huntington's disease

Behavioural Brain Research

Volumn 152, Issue 2, 2004, Pages 375-383

  Scattoni, Maria Luisa ^a   Valanzano, Angelina ^a   Popoli, Patrizia ^a   Pezzola, Antonella ^a   Reggio, Rosaria ^a   Calamandrei, Gemma ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Dopaminergic system; Exploration; Huntington's disease; Rat; Spatial open field; Striatum

Indexed keywords

QUINOLINIC ACID;

ANALYTIC METHOD; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE COURSE; EXPLORATORY BEHAVIOR; GROOMING; HUNTINGTON CHOREA; MALE; NONHUMAN; OPEN FIELD BEHAVIOR; OPEN FIELD TEST; PRIORITY JOURNAL; RAT; REARING; SPATIAL DISCRIMINATION; TASK PERFORMANCE;

ANIMALS; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; EXPLORATORY BEHAVIOR; HUNTINGTON DISEASE; MALE; MOTOR ACTIVITY; QUINOLINIC ACID; RATS; RATS, WISTAR; SPACE PERCEPTION; TIME FACTORS;

EID: 2942532898     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2003.10.021     Document Type: Article

References (38)

1. The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993;72:971-83.
2. Araujo D.M., Cherry S.R., Tatsukawa K.J., Toyokuni T., Kornblum H.I. Deficits in striatal dopamine D(2) receptors and energy metabolism detected by in vivo microPET imaging in a rat model of Huntington's disease. Exp. Neurol. 166:2000;287-297
3. Bates G.P., Mangiarini L., Mahal A., Davies S.W. Transgenic models of Huntington's disease. Hum. Mol. Genet. 6:1997;1633-1637
4. Beal M.F., Ferrante R.J., Swartz K.J., Kowall N.W. Chronic quinolinic acid lesions in rats closely resemble Huntington's disease. J. Neurosci. 11:1991;1649-1659
5. Beal M.F., Kowall N.W., Ellison D.W., Mazurek M.F., Swartz K.J., Martin J.B. Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature. 321:1986;168-171
6. Beal M.F., Kowall N.W., Swartz K.J., Ferrante R.J., Martin J.B. Systemic approaches to modifying quinolinic acid striatal lesions in rats. J. Neurosci. 8:1988;3901-3908
7. Carey R.J., DePalma G., Damianopoulos E. Cocaine-conditioned behavioral effects: a role for habituation processes. Pharmacol. Biochem. Behav. 74:2003;701-712
8. Choleris E., Thomas A.W., Kavaliers M., Prato F.S. A detailed ethological analysis of the mouse open field test: effects of diazepam, chlordiazepoxide and an extremely low frequency pulsed magnetic field. Neurosci. Biobehav. Rev. 25:2001;235-260
9. Clifford J.J., Drago J., Natoli A.L., Wong J.Y., Kinsella A., Waddington J.L., et al. Essential fatty acids given from conception prevent topographies of motor deficit in a transgenic model of Huntington's disease. Neuroscience. 109:2002;81-88
10. Clifford J.J., Tighe O., Croke D.T., Sibley D.R., Drago J., Waddington J.L. Topographical evaluation of the phenotype of spontaneous behaviour in mice with targeted gene deletion of the D1A dopamine receptor: paradoxical elevation of grooming syntax. Neuropharmacology. 37:1998;1595-1602
11. Dracheva S., Xu M., Kelley K.A., Haroutunian V., Holstein G.R., Haun S., et al. Paradoxical locomotor behavior of dopamine D1 receptor transgenic mice. Exp. Neurol. 157:1999;169-179
12. Ferre S., Fredholm B.B., Morelli M., Popoli P., Fuxe K. Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia. Trends Neurosci. 20:1997;482-487
13. Furtado J.C., Mazurek M.F. Behavioral characterization of quinolinate-induced lesions of the medial striatum: relevance for Huntington's disease. Exp. Neurol. 138:1996;158-168
14. Haik K.L., Shear D.A., Schroeder U., Sabel B.A., Dunbar G.L. Quinolinic acid released from polymeric brain implants causes behavioral and neuroanatomical alterations in a rodent model of Huntington's disease. Exp. Neurol. 163:2000;430-439
15. Hodgson J.G., Agopyan N., Gutekunst C.A., Leavitt B.R., LePiane F., Singaraja R., et al. A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration. Neuron. 23:1999;181-192
16. Homberg J.R., van den Akker M., Raaso H.S., Wardeh G., Binnekade R., Schoffelmeer A.N., et al. Enhanced motivation to self-administer cocaine is predicted by self-grooming behaviour and relates to dopamine release in the rat medial prefrontal cortex and amygdala. Eur. J. Neurosci. 15:2002;1542-1550
17. Jakel R.J., Maragos W.F. Neuronal cell death in Huntington's disease: a potential role for dopamine. Trends Neurosci. 23:2000;239-245
18. Jolles J., Rompa-Barendregt J., Gispen W.H. Novelty and grooming behavior in the rat. Behav. Neural. Biol. 25:1979;563-572
19. Jousselin-Hosaja M., Tobin C., Venault P., Joubert C., Chapouthier G. Effects of adrenal medulla graft on recovery of GABAergic and dopaminergic neuron deficits in mice: behavioural, pharmacological and immunohistochemical study. Behav. Brain Res. 140:2003;185-193
20. Marshall FJ, Shoulson I. Clinical features and treatment of Huntington's disease. In: Watt RL, Koller WC, editors. Movement disorders: neurologic principles and practice. New York: McGraw-Hill; 1997. p. 491-502.
21. Martin J.B. Huntington's disease: new approaches to an old problem. The Robert Wartenberg lecture. Neurology. 34:1984;1059-1072
22. Menalled L.B., Sison J.D., Wu Y., Olivieri M., Li X.J., Li H., et al. Early motor dysfunction and striosomal distribution of huntingtin microaggregates in Huntington's disease knock-in mice. J. Neurosci. 22:2002;8266-8276
23. Morell V. Huntington's gene finally found. Science. 260:1993;28-30
24. Noldus L.P. The Observer: a software system for collection and analysis of observational data. Behav. Res. Methods Instr. Comp. 23:1991;415-429
25. Popoli P., Pezzola A., Domenici M.R., Sagratella S., Diana G., Caporali M.G., et al. Behavioral and electrophysiological correlates of the quinolinic acid rat model of Huntington's disease in rats. Brain Res. Bull. 35:1994;329-335
26. Popoli P., Pintor A., Domenici M.R., Frank C., Tebano M.T., Pezzola A., et al. Blockade of striatal adenosine A2A receptor reduces, through a presynaptic mechanism, quinolinic acid-induced excitotoxicity: possible relevance to neuroprotective interventions in neurodegenerative diseases of the striatum. J. Neurosci. 22:2002;1967-1975
27. Poucet B. Object exploration, habituation, and response to a spatial change in rats following septal or medial frontal cortical damage. Behav. Neurosci. 103:1989;1009-1016
28. Ricceri L., Usiello A., Valanzano A., Calamandrei G., Frick K., Berger-Sweeney J. Neonatal 192 IgG-saporin lesions of basal forebrain cholinergic neurons selectively impair response to spatial novelty in adult rats. Behav. Neurosci. 113:1999;1204-1215
29. Rogers R.D., Baunez C., Everitt B.J., Robbins T.W. Lesions of the medial and lateral striatum in the rat produce differential deficits in attentional performance. Behav. Neurosci. 115:2001;799-811
30. Russell K.H., Giordano M., Sanberg P.R. Amphetamine-induced on- and off-wall rearing in adult laboratory rats. Pharmacol. Biochem. Behav. 26:1987;7-10
31. Sanberg P.R., Calderon S.F., Giordano M., Tew J.M., Norman A.B. The quinolinic acid model of Huntington's disease: locomotor abnormalities. Exp. Neurol. 105:1989;45-53
32. Shear D.A., Dong J., Gundy C.D., Haik-Creguer K.L., Dunbar G.L. Comparison of intrastriatal injections of quinolinic acid and 3-nitropropionic acid for use in animal models of Huntington's disease. Prog. Neuropsychopharmacol. Biol. Psychiatry. 22:1998;1217-1240
33. Spruijt B.M., van Hooff J.A., Gispen W.H. Ethology and neurobiology of grooming behavior. Physiol. Rev. 72:1992;825-852
34. Thiel C.M., Muller C.P., Huston J.P., Schwarting R.K. High versus low reactivity to a novel environment: behavioural, pharmacological and neurochemical assessments. Neuroscience. 93:1999;243-251
35. Vallone D., Pignatelli M., Grammatikopoulos G., Ruocco L., Bozzi Y., Westphal H., et al. Activity, non-selective attention and emotionality in dopamine D2/D3 receptor knock-out mice. Behav. Brain Res. 130:2002;141-148
36. Waddington J.L., Daly S.A., Downes R.P., Deveney A.M., McCauley P.G., O'Boyle K.M. Behavioural pharmacology of 'D-1-like' dopamine receptors: further subtyping, new pharmacological probes and interactions with 'D-2-like' receptors. Prog. Neuropsychopharmacol. Biol. Psychiatry. 19:1995;811-831
37. Wilcox RG. New statistical procedures for the social sciences. Hillsdale NJ: Erlbaum; 1987.
38. Xu M., Moratalla R., Gold L.H., Hiroi N., Koob G.F., Graybiel A.M., et al. Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses. Cell. 79:1994;729-742